Treatment response rate and life prognosis at autoimmune liver diseases
The aim of review. To carry out comparative analysis of modern studies, to characterize actual modes of treatment and to define prognosis and features of treatment response at various autoimmune liver diseases.Key points. Diagnostics and treatment are the most complex and insufficiently investigated...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2015-10-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/1068 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860119416340480 |
|---|---|
| author | K. V. Ivashkin Ye. N. Shirokova V. T. Ivashkin |
| author_facet | K. V. Ivashkin Ye. N. Shirokova V. T. Ivashkin |
| author_sort | K. V. Ivashkin |
| collection | DOAJ |
| description | The aim of review. To carry out comparative analysis of modern studies, to characterize actual modes of treatment and to define prognosis and features of treatment response at various autoimmune liver diseases.Key points. Diagnostics and treatment are the most complex and insufficiently investigated aspects of autoimmune liver diseases. Due to large studies, clinicians gain some understanding of approaches to therapy of these patients. Article presents up-to-date management algorithms and new promising agents, demonstrates complexities and alternative variants of treatment of autoimmune liver diseases.Conclusion. Appropriate and long-term (for 12–24 months) therapy of autoimmune diseases in most cases allows to achieve sustained response and in several folds surpasses efficacy of short courses (6–12 months). |
| format | Article |
| id | doaj-art-35ea727d21de4fce89d73792704270e6 |
| institution | Kabale University |
| issn | 1382-4376 2658-6673 |
| language | Russian |
| publishDate | 2015-10-01 |
| publisher | Gastro LLC |
| record_format | Article |
| series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| spelling | doaj-art-35ea727d21de4fce89d73792704270e62025-02-10T16:14:34ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732015-10-012554656673Treatment response rate and life prognosis at autoimmune liver diseasesK. V. Ivashkin0Ye. N. Shirokova1V. T. Ivashkin2State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationState educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian FederationThe aim of review. To carry out comparative analysis of modern studies, to characterize actual modes of treatment and to define prognosis and features of treatment response at various autoimmune liver diseases.Key points. Diagnostics and treatment are the most complex and insufficiently investigated aspects of autoimmune liver diseases. Due to large studies, clinicians gain some understanding of approaches to therapy of these patients. Article presents up-to-date management algorithms and new promising agents, demonstrates complexities and alternative variants of treatment of autoimmune liver diseases.Conclusion. Appropriate and long-term (for 12–24 months) therapy of autoimmune diseases in most cases allows to achieve sustained response and in several folds surpasses efficacy of short courses (6–12 months).https://www.gastro-j.ru/jour/article/view/1068autoimmune hepatitisprimary biliary cirrhosisprimary sclerosing cholangitisoverlap syndromes |
| spellingShingle | K. V. Ivashkin Ye. N. Shirokova V. T. Ivashkin Treatment response rate and life prognosis at autoimmune liver diseases Российский журнал гастроэнтерологии, гепатологии, колопроктологии autoimmune hepatitis primary biliary cirrhosis primary sclerosing cholangitis overlap syndromes |
| title | Treatment response rate and life prognosis at autoimmune liver diseases |
| title_full | Treatment response rate and life prognosis at autoimmune liver diseases |
| title_fullStr | Treatment response rate and life prognosis at autoimmune liver diseases |
| title_full_unstemmed | Treatment response rate and life prognosis at autoimmune liver diseases |
| title_short | Treatment response rate and life prognosis at autoimmune liver diseases |
| title_sort | treatment response rate and life prognosis at autoimmune liver diseases |
| topic | autoimmune hepatitis primary biliary cirrhosis primary sclerosing cholangitis overlap syndromes |
| url | https://www.gastro-j.ru/jour/article/view/1068 |
| work_keys_str_mv | AT kvivashkin treatmentresponserateandlifeprognosisatautoimmuneliverdiseases AT yenshirokova treatmentresponserateandlifeprognosisatautoimmuneliverdiseases AT vtivashkin treatmentresponserateandlifeprognosisatautoimmuneliverdiseases |